Go Deep
Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 12,208 | 269.3 | 18.56 | 0.01 | 11,705.55 |
| Oct 2026 | 12,094 | 269.3 | 18.56 | 0.01 | 11,602.79 |
| Oct 2026 | 12,502 | 261.8 | 18.04 | 0.01 | 11,218.53 |
| Oct 2026 | 12,687 | 258.3 | 17.80 | 0.01 | 11,035.75 |
| Oct 2026 | 13,020 | 257.7 | 17.36 | 0.01 | 10,765.73 |
| Oct 2026 | 13,406 | 244.8 | 16.87 | 0.01 | 10,433.80 |
| Oct 2026 | 13,176 | 249.1 | 17.17 | 0.01 | 10,628.92 |
| Oct 2026 | 12,661 | 258.8 | 17.84 | 0.01 | 11,041.37 |
| Oct 2026 | 12,682 | 258.4 | 17.81 | 0.01 | 10,998.01 |
| Oct 2026 | 13,721 | 238.9 | 16.46 | 0.01 | 10,147.01 |
Corcept Therapeutics Incorporated Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 256,147,000.0 | 164,903,000.0 | 202,125,000.0 | 207,638,000.0 |
| Net Profit | 42,987,000.0 | -31,761,000.0 | 24,288,000.0 | 19,668,000.0 |
| EPS | 0.4 | -0.3 | 0.2 | 0.2 |
Corcept Therapeutics Incorporated Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 761,407,000.0 | 675,040,000.0 | 482,375,000.0 | 401,858,000.0 | — |
| Net Profit | 99,652,000.0 | 141,209,000.0 | 106,140,000.0 | 101,418,000.0 | — |
| EPS | 0.9 | 1.4 | 1.0 | 0.9 | — |
Corcept Therapeutics Incorporated Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 836,651,000.0 | 840,553,000.0 | 621,517,000.0 | 583,430,000.0 | — |
| Total Liabilities | 188,846,000.0 | 160,964,000.0 | 114,812,000.0 | 81,588,000.0 | — |
| Total Equity | 647,805,000.0 | 679,589,000.0 | 506,705,000.0 | 501,842,000.0 | — |
Owes vs Owns
Corcept Therapeutics Incorporated owed $0.21 for every $1 it owned in Jun 2026, up from $0.14 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.21× | 0.23× | 0.19× | 0.18× | 0.14× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Corcept Therapeutics Incorporated Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 44.5%Receivables 7.1%Inventory 1.5%Fixed assets (tangible) 0.8%Long-term investments 19.2%Other assets 26.9%
How it's funded — Dec 2025
Long-term debt 0.6%Payables 4.8%Other liabilities 17.0%Shareholders' equity 77.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 372.2 | 383.3 | 368.2 | 431.7 |
| Receivables | 59.8 | 54.0 | 55.1 | 45.1 |
| Inventory | 12.9 | 12.4 | 7.7 | 6.1 |
| Fixed assets (tangible) | 6.5 | 8.0 | 0.3 | 1.8 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 160.3 | 219.8 | 57.2 | 4.9 |
| Other assets | 225.1 | 163.0 | 133.0 | 93.9 |
| Liabilities & equity | ||||
| Short-term debt | 1.1 | 0.8 | 0.2 | 1.1 |
| Long-term debt | 5.0 | 6.1 | 0.0 | 0.0 |
| Payables | 40.4 | 15.4 | 17.4 | 12.0 |
| Other liabilities | 142.3 | 138.7 | 97.3 | 68.5 |
| Shareholders' equity | 647.8 | 679.6 | 506.7 | 501.8 |
| Net tangible assets | 647.8 | 679.6 | 506.7 | 501.8 |
Corcept Therapeutics Incorporated Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 141,996,000.0 | 198,295,000.0 | 126,681,000.0 | 120,323,000.0 | — |
| Investing Activities | 69,758,000.0 | -177,604,000.0 | 90,906,000.0 | -114,327,000.0 | — |
| Financing Activities | -220,366,000.0 | -28,349,000.0 | -148,723,000.0 | -17,284,000.0 | — |